The invention relates to the use of Angiotensin converting enzyme 2 (ACE2) for the preparation of a medicament for the treatment of severe acute lung injury, especially induced by acid aspiration or sepsis, of lung oedemas and lung injuries and failures connected with infection with severe acute respiratory syndrome (SARS) coronavirus.
本发明涉及利用
血管紧张素转换酶 2(ACE2)制备一种药物,用于治疗严重急性肺损伤,特别是由吸酸或败血症引起的肺损伤、肺
水肿以及与严重急性呼吸系统综合征(
SARS)冠状病毒感染有关的肺损伤和衰竭。